Phase Ib/II study assessing the neo-adjuvant combination therapy of vinflunine with cisplatin followed by radical cystectomy in patients with muscle-invasive bladder cancer
Withdrawn prior to enrolment
Phase of Trial: Phase I/II
Latest Information Update: 16 Feb 2018
At a glance
- Drugs Cisplatin (Primary) ; Vinflunine (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- Acronyms JaNEO
- 12 Feb 2018 Planned End Date changed from 1 Jun 2020 to 1 Jul 2017.
- 12 Feb 2018 Planned primary completion date changed from 1 Sep 2019 to 1 Jul 2017.
- 12 Feb 2018 Status changed to withdrawn prior to enrolment.